Our findings revealed that both agents individually and synergistically inhibit the activation of Jak2 and subsequent phosphorylation of Stat3, a critical transcription factor involved in promoting cell survival and proliferation in neuroblastoma. This evidence concerns the gene JAK2 and neuroblastoma.